Helvetica Chimica Acta – Vol. 93 (2010)
2437
Experimental Part
General. 1-Azido-2,3,4,6-tetrakis-O-pivaloyl-b-d-glucopyranose (1) was prepared according to [15].
Other chemicals and solvents were either purchased or purified by standard techniques. Anal. TLC:
Merck precoated TLC (silica gel 60 F 254) plates. GC: Varian 3900 gas chromatograph with an octakis(6-
o-methyl-2,3-di-o-pentyl)-r-CD column of Chrompack CP-9000 (CP-Sil-8, 30 m ꢁ 0.32 mm; 75 kPa of
H2) under the condition given. M.p.: X4-Data microscopic melting-point apparatus; uncorrected. Optical
rotations: ADP 440 polarimeter in CH2Cl2. IR Spectra: Nicolet 380 FT-IR spectrophotometer; KBr discs.
1H-, 13C-, and 31P-NMR spectra: Bruker Avance 400 spectrometer in CDCl3 with TMS or H3PO4 as
internal standard. ESI-MS: Bruker Esquire 3000 plus spectrometer. Elemental analyses: Carlo-Erba 1106
instrument.
General Procedure for the Preparation of the 1H-[1,2,3]Triazole 3. To a mixture of 1 (541 mg,
1.0 mmol) and alkynes 2 (1.0 mmol) in t-BuOH (1 ml), 0.5 ml of an aq. soln. of CuSO4 (50 mg, 0.2 mmol)
and 0.5 ml of an aq. soln. of sodium ascorbate (79.2 mg, 0.4 mmol) were added. The mixture was stirred
vigorously for 24 h. The suspended product was filtered and washed with H2O. The crude product was
purified by column chromatography (CC; SiO2; hexane/AcOEt mixtures of increasing polarity) to afford
the triazole products.
4-Phenyl-1-[2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-d-glucopyranosyl]-1H-[1,2,3]triazole (3a).
Yellow solid. Yield: 92.3%. M.p. 216 – 2208. IR: 2970, 2077, 1744, 1637, 1481, 1400, 1368, 1280, 1140,
1037. 1H-NMR: 8.05 (s, 1 H); 7.85 (d, J ¼ 7.6, 2 H); 7.46 (d, J ¼ 7.6, 2 H); 7.38 (t, J ¼ 7.2, 1 H); 5.87 (d, J ¼
4.0, 1 H); 5.55 (t, J ¼ 4.4, 1 H); 5.36 (t, J ¼ 5.6, 1 H); 4.71 – 4.74 (m, 1 H); 4.55 – 4.59 (m, 1 H); 4.31 – 4.35
(m, 1 H); 0.92 – 1.25 (m, 12 Me). 13C-NMR: 177.8; 176.5; 147.4; 144.6; 129.0; 127.9; 127.6; 125.0; 85.1;
74.6; 71.1; 69.2; 66.2; 60.4; 37.8; 25.8; 26.1. ESI-MS: 643.2 ([M þ H]þ). Anal. calc. for C34H49N3O9: C
63.43, H 7.67, N 6.53; found: C 63.44, H 7.66, N 6.55.
2-{1-[2,3,4,6-Tetrakis-O-(2,2-dimethylpropanoyl)-d-glucopyranosyl]-1H-[1,2,3]triazol-4-yl}pyridine
(3b). Yellow solid. Yield: 95.3%. M.p. 179 – 1818. 1H-NMR: 8.60 (s, 1 H); 8.37 (d, J ¼ 3.6, 1 H); 8.11 (t,
J ¼ 6.8, 1 H); 7.78 (t, J ¼ 6.0, 1 H); 7.27 (d, J ¼ 12.2, 1 H); 5.97 (d, J ¼ 8.2, 1 H); 5.54 – 5.56 (m, 2 H); 5.32 –
5.37 (m, 1 H); 4.19 – 4.21 (m, 2 H); 4.05 (d, J ¼ 2.4, 1 H); 1.87 – 1.89 (m, 1 H); 0.94 – 1.21 (m, 12 Me).
13C-NMR: 177.7; 177.1; 177.1; 155.3; 149.2; 137.2; 131.4; 129.5; 123.6; 97.6; 78.2; 73.7; 69.2; 69.8; 62.4; 36.8;
25.79; 26.12. IR: 3431, 2974, 1742, 1601, 1479, 1400, 1281, 1141, 1034. Anal. calc. for C33H48N4O9: C 61.55,
H 7.82, N 8.78; found: C 61.58, H 7.80, N 8.75.
4-(4-Bromophenyl)-1-[2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-d-glucopyranosyl]-1H-[1,2,3]tri-
azole (3c). Yellow solid. Yield: 88.1%. M.p. 220 – 2228. IR: 3422, 2974, 1742, 1637, 1481, 1403, 1368, 1140,
1040. 1H-NMR: 7.97 (s, 1 H); 7.70 (d, J ¼ 5.6, 2 H); 7.56 (t, J ¼ 7.2, 2 H); 5.99 (d, J ¼ 7.6, 1 H); 5.52 – 5.55
(m, 2 H); 5.36 (d, J ¼ 4.2, 1 H); 4.18 – 4.21 (m, 2 H); 4.06 – 4.09 (m, 1 H); 0.92 – 1.25 (m, 12 Me).
13C-NMR: 177.7; 176.7; 131.9; 129.7; 127.2; 122.4; 85.9; 77.2; 71.8; 69.9; 66.9; 61.1; 38.8; 25.53; 26.92. Anal.
calc. for C34H48BrN3O9: C 56.62, H 6.73, N 5.93; found: C 56.65, H 6.70, N 5.91.
4-(4-Fluorophenyl)-1-[2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-d-glucopyranosyl]-1H-[1,2,3]tri-
azole (3d). White solid. Yield: 89.1%. M.p. 190 – 1928. IR: 3436, 2976, 1740, 1641, 1485, 1406, 1360, 1141,
1039. 1H-NMR: 8.02 (s, 1 H); 7.82 (d, J ¼ 7.2, 2 H); 7.82 (t, J ¼ 6.0, 2 H); 5.96 (d, J ¼ 6.6, 1 H); 5.54 – 5.58
(m, 2 H); 5.38 (d, J ¼ 2.4, 1 H); 4.11 – 4.20 (m, 2 H); 4.11 (d, J ¼ 12.4, 1 H); 0.95 – 1.26 (m, 12 Me).
13C-NMR: 178.7; 176.9; 132.1; 129.7; 127.2; 122.4; 85.9; 77.2; 71.9; 69.9; 66.9; 61.2; 38.7; 25.5; 26.9. Anal.
calc. for C34H48FN3O9: C 61.76, H 7.22, N 6.43; found: C 61.73, H 7.20, N 6.45.
4-(4-Methylphenyl)-1-[2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-d-glucopyranosyl]-1H-[1,2,3]tri-
azole (3e). White solid. Yield: 92.6%. M.p. 208 – 2108. IR: 3443, 2352, 2118, 1746, 1649, 1540, 1398, 1280,
1146. 1H-NMR: 8.00 (s, 1 H); 7.74 (d, J ¼ 5.6, 2 H); 7.25 (t, J ¼ 6.8, 2 H); 5.86 (d, J ¼ 11.6, 1 H); 5.55 (d,
J ¼ 4.2, 1 H); 5.31 – 5.34 (m, 1 H); 4.71 (m, 2 H); 4.45 (d, J ¼ 2.2, 1 H); 4.30 (d, J ¼ 6.2, 1 H); 2.39 (s,
1 H); 0.92 – 1.25 (m, 12 Me). 13C-NMR: 177.4; 176.2; 176.2; 144.3; 137.9; 129.1; 126.5; 126.2; 115.9; 86.2;
76.8; 76.2; 66.0; 65.9; 60.0; 38.4; 29.19; 26.47. Anal. calc. for C35H51N3O9: C 63.86, H 7.74, N 6.50; found: C
63.86, H 7.74, N 6.50.
General Procedure for the Preparation of the Ligand 4b (¼2-{5-(Diphenylphosphanyl)-1-[2,3,4,6-
tetrakis-O-(2,2-dimethylpropanoyl)-b-d-glucopyranosyl]-1H-[1,2,3]triazol-4-yl}pyridine). In a 20-ml
Schlenk tube containing a magnetic stirring bar were charged triazole 3b 1.28 g (2.0 mmol) and dry